The nominations for this year's The Pathologist Power List are open.
11/15/2019 | Fernando Lopez-Rios
Next-generation sequencing is changing the future of precision oncology with its ability to test for NTRK gene fusions and more
11/10/2019 | Sponsored by Deep Bio
AI diagnostics offer great potential for the future – and as a disease of many challenges, prostate cancer is a great first target
11/07/2019 | Kimia Sobhani, Jennifer Van Eyk
Remote self-sampling may improve diagnosis and prognosis while reducing costs, but numerous factors must be considered for appropriate implementation
10/30/2019 | Anoop Grewal
In-depth analysis of next-generation sequencing can help personalize cancer treatment and drive the adoption of precision medicine
10/29/2019 | Michael Schubert
In today’s increasingly connected society, how can digital pathology facilitate long-distance diagnosis and ease resource pressures across the globe?
10/18/2019 | Luke Turner
An analysis of 1,000 Swedish genomes reveals greater heterogeneity and shows why the human reference genome needs updating
10/12/2019 | Michael Schubert
Pharmacogenomic testing can only improve patient care if it’s clinically validated, judiciously applied, and easily understood by healthcare providers
08/23/2019 | Luke Turner
A new genomic barcode tracker could help spot the rare immune cells that are most effective against cancer
08/11/2019 | Jonathan James
The combination of genome-scale CRISPR experiments and powerful computational approaches has created a Cancer Dependency Map
07/23/2019 | Sumit Mohan
Kidney discard rates are higher than ever – but the procurement biopsies that often rule out their use are unreliable and need to be standardized
Register to access our FREE online portfolio, request the magazine in print and manage your preferences.
Register
To Screen, or not to Screen?
Women in Pathology
The Matchmakers